4745.TWO · CMH
Taiwan · RS rating 12 · As of 2026-10-08
| Price | 12.20 TWD |
|---|---|
| 1-day change | +0.4% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 65 / 24 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 16 / 10 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | +12.5% |
| Sales growth Q/Q | +21.6% |
| Distance from 52-week high | +54.6% |
| Market cap (USD) | $25.3M |